Subscribe to our YouTube channel for free here:
https://sc.mp/subscribe-youtube
Chinese pharmaceutical companies are trying to keep up with the surge in demand for fever-reducing medicine, as the country grapples with a spike in Covid-19 cases after Beijing ended its strict zero-Covid policy late 2022. Officials say production of paracetamol and ibuprofen has risen to four times as much as early December’s output.
Support us:
https://subscribe.scmp.com
Follow us on:
Website: https://www.scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/
#scmp #China #CoronavirusChina
Comments
Comments are disabled for this post.